Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Introduction of a polynucleotide molecule into or...
Reexamination Certificate
2007-10-31
2011-11-22
Marvich, Maria (Department: 1633)
Chemistry: molecular biology and microbiology
Process of mutation, cell fusion, or genetic modification
Introduction of a polynucleotide molecule into or...
C800S278000
Reexamination Certificate
active
08062891
ABSTRACT:
Methods and compositions for delivering polynucleotides are provided. One embodiment provides a non-viral vector comprising a recombinant polynucleotide-binding protein comprising a protein transduction domain operably linked to a targeting signal. Methods for modifying the genome of non-nuclear organelles are also provided.
REFERENCES:
patent: 5804445 (1998-09-01), Brasier
patent: 5831020 (1998-11-01), Citovsky
patent: 6017734 (2000-01-01), Summers
patent: 6127159 (2000-10-01), Fuller
patent: 6506559 (2003-01-01), Fire et al.
patent: 6531647 (2003-03-01), Baulcombe et al.
patent: 6759574 (2004-07-01), Ream, Jr. et al.
patent: 6835810 (2004-12-01), Hwu
patent: 6903077 (2005-06-01), Heintz
patent: 7001768 (2006-02-01), Wolffe
patent: 2002/0086356 (2002-07-01), Tuschl et al.
patent: 2002/0132990 (2002-09-01), Huston
patent: 2002/0155095 (2002-10-01), Nagabhushan
patent: 2003/0104622 (2003-06-01), Robbins et al.
patent: 2003/0186233 (2003-10-01), Chesnut et al.
patent: 2003/0237112 (2003-12-01), Brown et al.
patent: 2004/0072739 (2004-04-01), Anderson et al.
patent: 2004/0091878 (2004-05-01), Sera
patent: 2004/0176282 (2004-09-01), Dalby et al.
patent: 2005/0015830 (2005-01-01), Dorokhov et al.
patent: 2005/0042603 (2005-02-01), Wang
patent: 2005/0147993 (2005-07-01), Khan
patent: 2006/0211647 (2006-09-01), Khan
patent: 2007/0196334 (2007-08-01), Khan
patent: 2009/0123468 (2009-05-01), Khan
patent: 2009/0208478 (2009-08-01), Khan
patent: 2009/0227655 (2009-09-01), Khan
patent: 2272788 (2000-12-01), None
patent: 198 56 052 (2000-06-01), None
patent: 20030012226 (2003-02-01), None
patent: WO 97/27742 (1997-08-01), None
patent: WO 98/46271 (1998-10-01), None
patent: WO 98/56938 (1998-12-01), None
patent: WO 9856938 (1998-12-01), None
patent: WO 00/12732 (2000-03-01), None
patent: WO 00/19993 (2000-04-01), None
patent: WO 00/58488 (2000-10-01), None
patent: WO 01/75164 (2001-10-01), None
patent: WO 03/025195 (2003-03-01), None
patent: WO 03/052067 (2003-06-01), None
patent: WO 03/076561 (2003-09-01), None
patent: WO 2004/061456 (2004-07-01), None
patent: WO 2005/056752 (2005-06-01), None
Guo et al, Protein tolerance to random amino acid change, PNAS, 2004, vol. 101 (25), pp. 9205-9210.
Lesk et al, Prediction of Protein Function from Protein Sequence and Structure, p. 27 and 28, downloaded Sep. 16, 2007.
Sandig et al, abstract,. J Mol Med 73:B10 and Matsushima, Y. et al., JBiol Chem., 15;278(33):31149-58 (2003). Epub May 20, 2003.
Fortunati et al, A multi-domain protein for b1 integrin-targeted DNA delivery, Gene Therapy (2000) 7, 1505-1515.
Krueger et al, Peripheral-type benzodiazepine receptors mediate translocation of cholesterol from outer to inner mitochondrial membranes in adrenocortical cells, J. Biol. Chem., vol. 265, Issue 25, 15015-15022, Sep. 1990.
Futaki et al, Arginine-rich Peptides, The Journal of Biological Chemistry vol. 276, No. 8, Issue of Feb. 23, pp. 5836-5840, 2001.
Noguchi et al, Protein transduction technology offers a novel therapeutic approach for diabetes, J Hepatobiliary Pancreat Surg (2006) 13:306-313.
Anziano and Butow, “Splicing-defective mutants of the yeast mitochondrial COXI gene can be corrected by transformation with a hybrid maturase gene”,Proc. Natl. Acad. Sci. U.S.A., 88(13):5592-6 (1991).
Bhat and Epelboym, “Quantitative analysis of total mitochondrial DNA: competitive polymerase chain reaction versus real-time polymerase chain reaction”,J. Biochem. Mol. Toxicol., 18(4):180-6 (2004).
Carrozzo, et al., “Maternally-inherited Leigh syndrome-related mutations bolster mitochondrial-mediated apoptosis”,J. Neurochem., 90(2):490-501 (2004).
Cervin, et al., “Cosegregation of MIDD and MODY in a pedigree: functional and clinical consequences”,Diabetes, 53(7):1894-9 (2004).
Chen, et al., “Determination of normal ranges of mitochondrial respiratory activities by mtDNA transfer from 54 Human subjects to mtDNA-less HeLa cells for identification of the pathogenicities of mutated mtDNAs”,J. Biochem.(Tokyo), 135(2):237-43, 2004.
Claros and Vincens, “Computational method to predict mitochondrially imported proteins and their targeting sequences”,Eur. J. Biochem., 241(3):779-86 (1996).
D'Souza, et al., “DOAsome-mediated delivery of plasmid DNA toward mitochondria in living cells”,J.Control. Release, 92(1-2):189-97 (2003).
Falkenberg, et al., “Mitochondrial transcription factors B1 and B2 activate transcription of human mtDNA”,Nat. Genet., 31(3):289-94 (2002).
Grosschedl, et al., “HMG domain proteins: architectural elements in the assembly of nucleoprotein structures”,Trends Genet., 10(3):94-100 (1994).
Guy, et al., “Rescue of a mitochondrial deficiency causing Leber Hereditary Optic Neuropathy”,Ann. Neurol., 52(5):534-42 (2002).
Ignatovich, et al., “Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis mediated pathways”,J. Biol. Chem., 278(43):42625-36 (2003).
Khadake and Rao, “Condensation of DNA and chromatin by an SPKK-containing octapeptide repeat motif present in the C-terminus of histone H1”,Biochemistry, 36(5):1041-51 (1997).
Levy, et al., “Cytoplasmic transfer in oocytes: biochemical aspects”,Hum. Reprod. Update, 10(3):241-50 (2004).
Liu, et al., “Mitochondrial DNA mutation and depletion increase the susceptibility of human cells to apoptosis”,Ann. N.Y. Acad. Sci., 1011:133-45 (2004).
Lu and Hansen, “Revisiting the structure and functions of the linker histone C-terminal tail domain”,Biochem. Cell Biol., 81(3):173-6 (2003).
Luo and Saltzman, “Synthetic DNA delivery systems”,Nat. Biotechnol.,18(1):33-7 (2000).
Neupert, “Protein import into mitochondria”,Annu. Rev. Biochem., 66:863-917 (1997).
Oca-Cossio, et al., “Limitations of allotopic expression of mitochondrial genes in mammalian cells”,Genetics, 165(2):707-20 (2003).
Petros, et al., “mtDNA mutations increase tumorigenicity in prostate cancer”,Proc. Natl. Acad. Sci. U.S.A., 102(3):719-24 (2005).
Pineau, et al., “Targeting the NAD7 subunit to mitochondria restores a functional complex 1 and a wild type phenotype in theNicotiana sylvestrisCMS II mutant lacking nad7”,J. Biol. Chem., 280(28):25994-6001 (2005).
Prosite Documentation PD0C00305, “HMG boxes A and B and DNA-binding domains signature and profile”, updated Dec. 2004.
Rantanen and Larsson, “Regulation of mitochondrial DNA copy number during spermatogenesis”,Hum. Reprod., 15 Suppl 2:86-91 (2000).
Ross and Murphy, “Cell-penetrating peptides are excluded from the mitochondrial matrix”,Biochem. Soc. Trans., 32(Pt 6):1072-4 (2004).
Rossignol, et al., “Mitochondrial threshold effects”,Biochem. J., 370(Pt 3):751-62 (2003).
Roubertoux, et al., “Mitochondrial DNA modifies cognition in interaction with the nuclear genome and age in mice”,Nat. Genet., 35(1):65-9 (2003).
Roucou, et al., “Bioenergetic and structural consequences of allotopic expression of subunit 8 of yeast mitochondrial ATP synthase. The hydrophobic character of residues 23 and 24 is essential for maximal activity and structural stability of the enzyme complex”,Eur. J. Biochem., 261(2):444-51 (1999).
Schaefer, et al., “The epidemiology of mitochondrial disorders—past, present and future”,Biochim. Biophys. Acta, 1659(2-3):115-20 (2004).
Seibel, et al., “Transfection of mitochondria: strategy towards a gene therapy of mitochondrial DNA diseases”,Nucleic Acids Res., 23(1):10-7 (1995).
Smigrodzki and Khan, “Mitochondrial microheteroplasmy and a theory of aging and age-related disease”,Rejuvenation Res., 8(3):172-98 (2005).
Srivastava and Moraes, “Manipulating mitochondrial DNA heteroplasmy by a mitochondrially targeted restriction endonuclease”,Hum. Mol. Genet., 10(26):3093-9 (2001).
Stephens and Pepperkok, &#
Gencia Corporation
Marvich Maria
Pabst Patent Group LLP
LandOfFree
Nonviral vectors for delivering polynucleotides to plants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nonviral vectors for delivering polynucleotides to plants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nonviral vectors for delivering polynucleotides to plants will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4291200